Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration | #biotech # Market research # market # pharma
Like
Comment
Share
Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration | #biotech # Market research # market # pharma